BlinkLab

North Shore Pediatric Therapy in Chicago Joins BlinkLab’s US Registrational Study

BlinkLab Limited (ASX:BB1) (“BlinkLab”, or the “Company”), an innovative digital healthcare company developing AI-powered smartphone technology to transform the autism and ADHD diagnostic markets, is pleased to announce that North Shore Pediatric Therapy (“NSPT”) is joining our US clinical study. NSPT is the second US-based site to on-board for the 100-patient initial phase of the registrational study. Enrolment from the NSPT-site is expected to commence in the coming weeks.


  • US-based North Shore Pediatric Therapy (“NSPT”) is the second clinical site to join BlinkLab’s registrational study.
  • Located in the Chicago area, NSPT is a recognized leader in early autism intervention services, specializing in Applied Behavior Analysis (ABA), neuropsychology, speech therapy, occupational therapy, and mental health support.
  • The NSPT clinical trial site is set to begin patient recruitment and diagnostic testing in the coming weeks, supporting timely and efficient data collection for the study.
  • Together, with PriMED Clinical Research, these two leading US-based autism centers provide access to a large pool of diverse subjects that will accelerate the recruitment process and ensure high-quality data collection.

NSPT was selected for this study due to its extensive expertise in administering the ADOS-2 diagnostic tool, which is widely recognized as the gold standard for autism diagnosis. Their experienced neuropsychology team specializes in conducting comprehensive, play-based assessments that evaluate social, emotional, and communication behaviors, ensuring precise and reliable autism diagnoses. As part of our US registrational study, NSPT’s use of the ADOS-2 will serve as a critical benchmark for standard-of-care comparisons, helping validate the effectiveness of our Blinklab Dx 1 test.

In addition to their clinical expertise, NSPT provides access to a diverse population of children throughout the Chicago area, which is an essential factor in ensuring the study reflects a broad range of backgrounds and developmental profiles. Their ability to recruit children as young as 18 months old is particularly valuable for the BlinkLab study, as our mission is to enable early diagnosis and improve long-term outcomes for children with autism. With a strong track record in early intervention and autism diagnostics, NSPT’s participation enhances the study’s robustness, credibility, and real-world applicability, ultimately contributing to the advancement of Blinklab’s more accurate and accessible autism screening tool.


Click here for the full ASX Release

This article includes content from Blinklab Limited, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.

BB1:AU
The Conversation (0)
Tech 5: US Government Strikes Big Tech Deal, Perplexity Plots Expansion

Tech 5: US Government Strikes Big Tech Deal, Perplexity Plots Expansion

Tech stocks led Wall Street to a second consecutive week of gains as a series of data releases reignited optimism about a September interest rate cut from the US Federal Reserve.

A strong consumer price index report was the catalyst, renewing anticipation that the Fed will lower rates when it meets next month. While Thursday's (August 14) less optimistic producer price index report caused a momentary pause, the tech sector's resilience — or defiance — mitigated losses and kept momentum alive.

Here's a look at the key moments that shaped the tech sector this week.

Keep reading...Show less
Tesla cars parked near a Tesla sign with "Tech 5" graphic overlay.

Tech 5: Tesla Pulls Plug on Dojo, Chipmakers Largely Exempt from Trump's Tariffs

This week saw tech stocks push the Nasdaq Composite (INDEXNASDAQ:.IXIC) to its best week since June.

However, on Monday (August 4), multiple news outlets reported that various Wall Street firms were warning of a near-term drop in the S&P 500 (INDEXSP:.INX) after its strong rally. In a note to clients, Mike Wilson of Morgan Stanley (NYSE:MS) forecasts that tariffs, which went into effect this week, will lead to a 10 percent correction.

“Over the last couple of weeks, we have noted that investors should expect a modest pullback in the third quarter,” Wilson wrote. Julian Emanuel of Evercore (NYSE:EVR) anticipates a 15 percent drop. Additionally, Parag Thatte's team at Deutsche Bank (NYSE:DB) points to an overdue drawdown following three months of equity expansion.

Keep reading...Show less
ChatGPT logo overlayed on human profile.

How to Invest in OpenAI's ChatGPT

OpenAI’s ChatGPT is one of the latest technological breakthroughs in the artificial intelligence space. But what is ChatGPT, and can you invest in OpenAI?

This emerging technology is representative of a niche subsector of the AI industry known as generative AI — systems that can generate text, images or sounds in response to prompts given by users.

Precedence Research expects the global AI market to grow at a compound annual growth rate (CAGR) of 19.2 percent to reach US$3.68 trillion by 2034. Just how much of an impact OpenAI’s ChatGPT will have on this space is hard to predict, but Fortune Business Insights estimates that the total market revenue of generative AI will see a CAGR of 39.6 percent through 2032, increasing from US$67.18 billion last year to US$967.65 billion in 2032.

Keep reading...Show less
Skyscrapers with logos of Apple, Amazon and Microsoft; "Tech 5" text overlay.

Tech 5: Tesla and Samsung Strike Deal, Palo Alto to Acquire CyberArk

The stock market's momentum from earlier this week, which saw the S&P 500 (INDEXSP:.INX) and the Nasdaq Composite (INDEXNASDAQ:.IXIC) reach new record highs, came to a halt on Friday (August 1).

Investors were reacting to a series of mixed tech earnings reports. Many were accompanied by cautious forward-looking guidance despite strong top-line numbers. This sentiment was further soured by fresh economic data out of the US showing that while employment remains strong, there are signs inflation is reaccelerating.

The most significant blow, however, came from geopolitical developments that reignited global trade tensions, prompting new fears of retaliatory tariffs and the potential for a renewed surge in inflation.

Keep reading...Show less
Robotic hand and human hand reaching out to touch glowing brain.

ASX AI Stocks: 5 Biggest Companies in 2025

Artificial intelligence (AI) continues to evolve and advance rapidly, becoming increasingly integrated in the automation of everyday life and a focal point of growth in the technology sector.

According to a September 2023 report from IDC on worldwide AI spending, Australia is leading the Asia-Pacific region in spending on AI solutions along with Korea and India; the three countries are also leading when it comes to AI adoption in the area. Spending in the region, excluding Japan and China, is expected to reach US$28.2 billion by 2027.

Although the AI market is relatively small in Australia, it’s growing. To help investors understand the options available, the Investing News Network used TradingView's stock screener to find the top AI stocks on ASX by market cap. All ASX AI stocks data was current as of July 11, 2025. Companies whose businesses are focused mainly on AI were considered.

Keep reading...Show less

Latest Press Releases

Related News

×